Showing 1 - 6 results of 6 for search 'Aleksandr V. Kudriavtsev', query time: 0.03s Refine Results
  1. 1
    Immune Escape Associated with RBD Omicron Mutations and SARS-CoV-2 Evolution Dynamics

    Immune Escape Associated with RBD Omicron Mutations and SARS-CoV-2 Evolution Dynamics by Aleksandr V. Kudriavtsev, Anna V. Vakhrusheva, Valery N. Novoseletsky, Marine E. Bozdaganyan, Konstantin V. Shaitan, Mikhail P. Kirpichnikov, Olga S. Sokolova

    Published 2022-07-01
    Get full text
    Article
  2. 2
    Abstract P-43: Approximating Protein Alpha-Helices with Cylinders for Free Electron Lasers Diffraction Experiments

    Abstract P-43: Approximating Protein Alpha-Helices with Cylinders for Free Electron Lasers Diffraction Experiments by Grigory A. Armeev, Mikhail A. Lozhnikov, Valery N. Novoseletsky, Aleksandr V. Kudriavtsev, Alexey К. Shaytan, Georgy M. Kobelkov, Konstantin V. Shaitan

    Published 2019-06-01
    Get full text
    Article
  3. 3
    Abstract P-47: Recognition of Single Particle’s Diffraction Images Generated in X-ray Free Electron Laser Experiments

    Abstract P-47: Recognition of Single Particle’s Diffraction Images Generated in X-ray Free Electron Laser Experiments by Mikhail A. Lozhnikov, Georgiy M. Kobelkov, Grigoriy A. Armeev, Aleksandr V. Kudriavtsev, Valery N. Novoseletsky, Alexey K. Shaytan, Konstantin V. Shaitan

    Published 2019-06-01
    Get full text
    Article
  4. 4
    Design and Immunological Properties of the Novel Subunit Virus-like Vaccine against SARS-CoV-2

    Design and Immunological Properties of the Novel Subunit Virus-like Vaccine against SARS-CoV-2 by Igor V. Krasilnikov, Aleksandr V. Kudriavtsev, Anna V. Vakhrusheva, Maria E. Frolova, Aleksandr V. Ivanov, Marina A. Stukova, Ekaterina A. Romanovskaya-Romanko, Kirill A. Vasilyev, Nataliya V. Mushenkova, Artur A. Isaev

    Published 2022-01-01
    Get full text
    Article
  5. 5
    SARS-CoV-2 Subunit Virus-like Vaccine Demonstrates High Safety Profile and Protective Efficacy: Preclinical Study

    SARS-CoV-2 Subunit Virus-like Vaccine Demonstrates High Safety Profile and Protective Efficacy: Preclinical Study by Anna V. Vakhrusheva, Aleksandr V. Kudriavtsev, Nickolay A. Kryuchkov, Roman V. Deev, Maria E. Frolova, Konstantin A. Blagodatskikh, Milana Djonovic, Andrey A. Nedorubov, Elena Odintsova, Aleksandr V. Ivanov, Ekaterina A. Romanovskaya-Romanko, Marina A. Stukova, Artur A. Isaev, Igor V. Krasilnikov

    Published 2022-08-01
    Get full text
    Article
  6. 6
    Safety and Immunogenicity of Betuvax-CoV-2, an RBD-Fc-Based SARS-CoV-2 Recombinant Vaccine: Preliminary Results of the First-in-Human, Randomized, Double-Blind, Placebo-Controlled Phase I/II Clinical Trial

    Safety and Immunogenicity of Betuvax-CoV-2, an RBD-Fc-Based SARS-CoV-2 Recombinant Vaccine: Preliminary Results of the First-in-Human, Randomized, Double-Blind, Placebo-Controlled... by Aleksandr V. Kudriavtsev, Anna V. Vakhrusheva, Nickolay A. Kryuchkov, Maria E. Frolova, Konstantin A. Blagodatskikh, Taras V. Ivanishin, Milana Djonovic, Ekaterina A. Romanovskaya-Romanko, Anton N. Kovalenko, Dmitry A. Lioznov, Tatiana G. Zubkova, Svetlana V. Teplykh, Rodion A. Oseshnyuk, Marina A. Stukova, Artur A. Isaev, Igor V. Krasilnikov

    Published 2023-02-01
    Get full text
    Article

Search Tools: